Schizophrenia and Comorbid Substance Abuse

Journal of the American Psychiatric Nurses Association

Volumn 5, Issue 2, 1999, Pages

  Littrell, Kimberly H ^a   Littrell, Steven H ^b  

^a Promedica Research Center   (United States)

^b FIELDING GRADUATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012711445     PISSN: 10783903     EISSN: None     Source Type: Journal    
DOI: 10.1177/107839039900500212     Document Type: Article

References (50)

1. Addington, J., & Addington, D. (1997). Substance abuse and cognitive functioning in schizophrenia. Journal of Psychiatry and Neuroscience, 122, 99-104.
2. Addington, J., & Addington, D. (1998). Effect of substance misuse in early psychosis. British Journal of Psychiatry, 172(Suppl. 133), 134-136.
3. Albanese, M. J. (1998, June). Safety and efficacy of risperidone in substance abusers with psychosis. Paper presented at the annual meeting of the New Clinical Drug Evaluation Unit, Boca Raton, FL.
4. Albanese, M. J., Khantzian, E. J., Murphy, S. L., & Green, A. I. (1994). Decreased substance use in chronically psychotic patients treated with clozapine [Letter to the editor]. American Journal of Psychiatry, 151, 780-781.
5. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders. (4th ed.). Washington, DC: Author.
6. Baigent, M., Holme, G., & Hafner, R. J. (1995). Self reports of the interaction between substance abuse and schizophrenia. Australian and New Zealand Journal of Psychiatry, 29, 69-74.
7. Bailey, L., Maxwell, S., & Brandabur, M. M. (1997). Substance abuse as a risk factor for tardive dyskinesia: A retrospective analysis of 1,027 patients. Psychopharmacology Bulletin, 33, 177-181.
8. Bartels, S. J., Teague, G. B., Drake, R. E., Clark, R. E., Bush, P. W., & Noordsy, D. L. (1993). Substance abuse in schizophrenia: Service utilization and cost. Journal of Nervous and Mental Disorders, 181, 227-232.
9. Boyd, J. H., Burke, J. D., Gruenberg, E., Holzer, C. E., Rae, D. S., George, L. K., Karno, M., Stoltzman, R., McEvoy, L., & Nestadt, G. (1984). Exclusion criteria of DSM-III. Archives of General Psychiatry, 41, 983-989.
10. Brady, K., Anton, R., Ballenger, J. C., Lydiard, R. B., Adinoff, B., & Selander, J. (1990). Cocaine abuse among schizophrenic patients. American Journal of Psychiatry, 147, 1164-1167.
11. Brady, K. T., Killeen, T., & Jarrell, P. (1993). Depression in alcoholic schizophrenic patients. American Journal of Psychiatry, 150, 1255-1256.
12. Buckley, P. F. (1998). Substance abuse in schizophrenia: A review. Journal of Clinical Psychiatry, 59(Suppl. 3), 26-30.
13. Buckley, P., Thompson, P., Way, L., & Meltzer, H. Y. (1994). Substance abuse among patients with treatment-resistant schizophrenia: Characteristics and implications for clozapine therapy. American Journal of Psychiatry, 151, 385-389.
14. Brunette, M. F., & Drake, R. W. (1997). Gender differences in patients with schizophrenia and substance abuse. Comprehensive Psychiatry, 38, 109-116.
15. Carey, K. B. (1996). Substance use reduction in the context of outpatient psychiatric treatment: A collaborative, motivational, harm reduction approach. Community Mental Health Journal, 32, 291-306.
16. Chouljian, T. L., Shumway, M., Balancio, E., Dwyer, E. V., Surber, R., & Jacobs, M. (1995). Substance use among schizophrenic outpatients: Prevalence, course, and relation to functional status. Annals of Clinical Psychiatry, 7, 19-24.
17. Conley, R. R., Kelly, D. L., & Gale, E. A. (1998). Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse. Schizophrenia Research, 33, 95-101.
18. Cuffel, B. J., & Chase, P. (1994). Remission and relapse of substance use disorders in schizophrenia: Results from a one-year prospective study. Journal of Nervous and Mental Disorders, 182, 342-348.
19. Cuffel, B. J., Heithoff, K. A., & Lawson, W. (1993). Correlates of patterns of substance abuse among patients with schizophrenia. Hospital and Community Psychiatry, 44, 247-251.
20. Cuffel, B. J., Shumway, M., Chouljian, T. L., & MacDonald, T. (1994). A longitudinal study of substance use and community violence in schizophrenia. journal of Nervous and Mental Disease, 182, 704-708.
21. De Quardo, J. R., Carpenter, C. F., & Tandon, R. (1994). Patterns of substance abuse in schizophrenia: Nature and significance. Journal of Psychiatric Research, 28, 267-275.
22. Dixon, L., Haas, G., Weiden, P. J., Sweeney, J., & Frances, A. J. (1991). Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. American Journal of Psychiatry, 148, 224-230.
23. D'Mello, D. A., Boltz, M. K., & Msibi, B. (1995). Relationship between concurrent substance abuse in psychiatric patients and neuroleptic dosage. American Journal of Drug and Alcohol Abuse, 21, 257-265.
24. Drake, R. E., McLaughlin, P., Pepper, B., & Minkoff, K. (1991). In K. Minkoff and R. E. Drake (Eds.), Dual diagnosis of mental illness and substance disorder (pp. 3-12). San Francisco: Jossey-Bass.
25. Drake, R. E., Osher, F. C., Noordsy, D. L., Hurlbut, S. C., Teague, G. B., & Beaudett, M. S. (1990). Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin, 16, 57-67.
26. Drake, R. E., & Wallach, M. A. (1989). Substance abuse among the chronically mentally ill. Hospital and Community Psychiatry, 40, 1041-1046.
27. Drake, R. E., & Wallach, M. A. (1993). Moderate drinking among people with severe mental illness. Hospital and Community Psychiatry, 44, 780-782.
28. Frances, R. J. (1996). Schizophrenia and substance abuse. Psychiatric Annals, 26, 523-527.
29. Hambrecht, M., & Hafner, H. (1996). Substance abuse and the onset of schizophrenia. Biological Psychiatry, 40, 155-163.
30. Haywood, T. W., Kravitz, H. M., Grossman, L. S., Cavanaugh, J. L., Davis, J. M., & Lewis, D. A. (1995). Predicting the “revolving door” phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry, 152, 856-861.
31. International Association of Psychosocial Rehabilitation Services. (1997). Practice guidelines for the psychiatric rehabilitation of persons with severe and persistent mental illness in a managed care environment. Columbia, MD: Author.
32. Khalsa, H. K., Shaner, A., Anglin, M. D., & Wang, J. (1991). Prevalence of substance abuse in a psychiatric evaluation unit. Drug and Alcohol Dependence, 28, 215-223.
33. Kirchner, J. E., Owen, R. R., Nordquist, C., & Fischer, E. P. (1998). Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatric Services, 49, 82-85.
34. Kovasznay, B., Fleischer, J., & Tanenberg-Karant, M. (1997). Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophrenia Bulletin, 23, 195-201.
35. Marcus, P., & Snyder, R. (1995). Reduction of comorbid substance abuse with clozapine [Letter to the editor]. American Journal of Psychiatry, 152, 959-959.
36. Meil, W. M., & Schecter, M. D. (1997). Olanzapine attentuates the reinforcing effects of cocaine. European Journal of Pharmacology, 340, 17-26.
37. Miller, N. S., Eriksen, A., & Owley, T. (1994). Psychosis and schizophrenia in alcohol and drug dependence. Psychiatric Annals, 24, 418-423.
38. Mueser, K. T., Bellack, A. S., & Blanchard, J. J. (1992). Comorbidity of schizophrenia and substance abuse: Implications for treatment. Journal of Consulting and Clinical Psychology, 60, 845-856.
39. Mueser, K. T., & Gingerich, S. (1994). Coping with schizophrenia: A guideforfamilies. Oakland, CA: New Harbinger.
40. Mueser, K. T., & Noordsy, D. L. (1996). Group treatment for dually diagnosed clients. In R. E. Drake & K. T. Mueser (Eds.), Dual diagnosis of major mental illness and substance abuse: Vol. 2. Recent research and clinical implications (pp. 33-51). San Francisco: Jossey-Bass.
41. Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47, 853-858.
42. Pristach, C. A., & Smith, C. M. (1996). Self-reported effects of alcohol use on symptoms of schizophrenia. Psychiatric Services, 47, 421-423.
43. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association, 264, 2511-2518.
44. Salokangas, R. K. R., Saarijarvi, S., Taiminen, T., Lehte, H., Niemi, H., Ahola, V., & Syvalahti, E. (1997). Effect of smoking on neuroleptics in schizophrenia. Schizophrenia Research, 23, 55-60.
45. Serper, M. R., Alpert, M., Richardson, N. A., Dickson, S., Allen, M. H., & Werner, A. (1995). Clinical effects of recent cocaine use on patients with acute schizophrenia. American Journal of Psychiatry, 152, 1464-1469.
46. Shaner, A., Khalsa, E., Roberts, L., Wilkins, J., Anglin, D., & Hsieh, S-C. (1993). Unrecognized cocaine use among schizophrenic patients. American Journal of Psychiatry, 150, 758-762.
47. Siris, S. G. (1990). Pharmacological treatment of substance-abusing schizophrenic patients. Schizophrenia Bulletin, 16, 111-122.
48. Stone, A. M., Greenstein, R. A., Gamble, G., & McLellan, A. T. (1993). Cocaine use by schizophrenic outpatients who are receiving depot neuroleptic medication. Hospital and Community Psychiatry, 44, 176-177.
49. Swofford, C. D., Kasckow, J. W., Scheller-Gilkey, G., & Inderbitzin, L. B. (1996). Substance use: A power predictor of relapse in schizophrenia. Schizophrenia Research, 20, 145-151.
50. Ziedonis, D. M., & Fisher, W. (1994). Assessment and treatment of comorbid substance abuse in individuals with schizophrenia. Psychiatric Annals, 24, 477-483.